FPF
PETX

FNY Partners Fund’s Aratana Therapeutics, Inc. PETX Stock Holding History

FNY Partners Fund’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-500
Closed -$2K – 1362
2017
Q1 		$2K Buy
+500
New +$3.38K ﹤0.01% 1305

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

FNY Partners Fund's PETX Position: Q2 2017 in Review

FNY Partners Fund sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2017, closing a stake of 500 shares — an estimated $2K sold.

FNY Partners Fund first reported a position in PETX in Q1 2017 and held it in 1 quarter. The position peaked at $2K in Q1 2017. 105 funds tracked by Wall St. Rank hold PETX as of Q2 2017.

  • FNY Partners Fund reported no remaining Aratana Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • FNY Partners Fund sold 500 Aratana Therapeutics, Inc. shares in Q2 2017, an estimated $2K.
  • FNY Partners Fund first reported a position in Aratana Therapeutics, Inc. in Q1 2017 and held it in 1 quarter.
  • FNY Partners Fund's Aratana Therapeutics, Inc. position peaked at $2K in Q1 2017.
  • 105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.